Generic approvals advancing in parallel The pipeline outlook arrives as Health Canada works through a queue of generic semaglutide submissions
Semaglutide and tirzepatide achieve approximately 15-20% body weight reduction in clinical trials
A test of the hypothesis that oxalate secretion produces proximal tubule crystallization in primary hyperoxaluria type I
To prevent autotoxicity, the vesicular monoamine transporter 2 (VMAT2) actively sequesters free cytoplasmic monoamines into vesicles (Lohr et al., 2014)
McLean BA, Wong CK, Campbell JE, Hodson DJ, Trapp S, Drucker DJ (2021) Revisiting the complexity of GLP-1 action from sites of synthesis to receptor activation
To learn more about weight loss medications, read Zappy Healths blog on GLP-1 medications for weight loss